Exploring the psychological effects of GTN treatment on women

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to understand the psychological impact of Gestational Trophoblastic Neoplasia (GTN) on women who have completed chemotherapy treatment. It involves conducting semi-structured telephone interviews with a sample of 20 women, who are between 6 weeks and 24 months post-treatment. The study seeks to gain insights into their emotional experiences, assess the adequacy of psychological support provided by health professionals, and identify sources of support accessed by patients after treatment. Thematic analysis will be employed to analyze the interview data and provide a comprehensive understanding of the patients' experiences.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Treated with chemotherapy for a GTN diagnosis
* Completed treatment between 6 weeks and 24 months
* Are able to provide informed consent
* Have no cognitive impairment as judged by the treating clinician

Exclusion Criteria:

* Treatment received less than 6 weeks ago
* Treatment received more than 24 months ago
* Non-English speaking

Where it's running

• Weston Park Hospital
  Sheffield, South Yorkshire, United Kingdom Recruiting

Study contacts

• Principal investigator: Kamaljit Singh — Nurse Consultant
• Study coordinator: Kamaljit Singh
• Email: kamaljitsingh@nhs.net
• Phone: 01142265274

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• A cohort study for patients with Gestational Trophoblastic Neoplasia

  This study is gathering information from patients with Gestational Trophoblastic Neoplasia to better understand their treatment and outcomes, including fertility and recurrence rates.

  Recruiting Women's Hospital School Of Medicine Zhejiang University · Zhengjiang, Hangzhou · NCT06681259

• Combination treatment of toripalimab and actinomycin-D for gestational trophoblastic neoplasia

  This study is testing if combining two drugs, toripalimab and actinomycin-D, can help people with gestational trophoblastic neoplasia respond better than just using actinomycin-D alone.

  Recruiting Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT06028672

• Using toripalimab and actinomycin-D to treat gestational trophoblastic neoplasia

  This study is testing if a new combination of toripalimab and actinomycin-D can effectively treat gestational trophoblastic neoplasia in patients with a specific score, to see if it works better than standard chemotherapy.

  Recruiting Phase 2 Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT06020755

• Camrelizumab plus apatinib for high‑risk gestational trophoblastic neoplasia

  This trial will test whether adding camrelizumab and apatinib to chemotherapy helps women with ultra high‑risk or chemo‑refractory/relapsed high‑risk gestational trophoblastic neoplasia achieve remission.

  Recruiting Phase 2 Peking Union Medical College Hospital · Beijing · NCT05139095

• Treatment options for hydatidiform mole with lung nodules

  This study is testing different treatment options for patients with hydatidiform mole and lung nodules to see which approach works best for getting their hormone levels back to normal.

  Recruiting Women's Hospital School Of Medicine Zhejiang University · Hangzhou, Zhejiang · NCT03785574

• Hysteroscopic Repeat Curettage as First-Line Treatment for Low-Risk Postmolar GTN

  This study tests whether hysteroscopic repeat curettage can be a first-line option for low-risk postmolar GTN, compared with methotrexate chemotherapy.

  Recruiting Phase 2 Women's Hospital School Of Medicine Zhejiang University · Hangzhou, Zhejiang · NCT03703271

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.